June 29 (Reuters) - Luye Pharma Group Ltd:
* CLINICAL TRIAL APPLICATION OF LURBINECTEDIN FOR INJECTION (LY01017) ACCEPTED BY CENTRE FOR DRUG EVALUATION OF PRC Source text for Eikon: Further company coverage:
Our Standards: The Thomson Reuters Trust Principles.